233 related articles for article (PubMed ID: 34784656)
21. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
[TBL] [Abstract][Full Text] [Related]
22. Supportive Care for Patients with Systemic Light Chain Amyloidosis.
Wong SW; Fogaren T
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1177-1191. PubMed ID: 33099432
[TBL] [Abstract][Full Text] [Related]
23. Systemic light-chain amyloidosis incidentally diagnosed after subtotal parathyroidectomy and thyroid lobectomy.
Tsai K; Yu AC; Livhits MJ; Sajed D; Leung AM; Cheung DS
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33875506
[TBL] [Abstract][Full Text] [Related]
24. Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.
Patel KS; Hawkins PN; Whelan CJ; Gillmore JD
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535224
[TBL] [Abstract][Full Text] [Related]
25. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
26. Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.
Nagano N; Yano T; Fujita Y; Kouzu H; Koyama M; Ikeda H; Yasui K; Muranaka A; Nishikawa R; Takahashi R; Kishiue N; Yuda S; Miura T
Heart Vessels; 2020 Apr; 35(4):521-530. PubMed ID: 31559459
[TBL] [Abstract][Full Text] [Related]
27. Natural history of thromboembolism in AL amyloidosis.
Halligan CS; Lacy MQ; Vincent Rajkumar S; Dispenzieri A; Witzig TE; Lust JA; Fonseca R; Gertz MA; Kyle RA; Pruthi RK
Amyloid; 2006 Mar; 13(1):31-6. PubMed ID: 16690498
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
Varga C; Dorbala S; Lousada I; Polydefkis MJ; Wechalekar A; Maurer MS; Comenzo RL
Blood Rev; 2021 Jan; 45():100720. PubMed ID: 32616304
[TBL] [Abstract][Full Text] [Related]
29. Reversing the poor prognosis of primary amyloid light‑chain amyloidosis with cardiac involvement.
Jurczyszyn A; Rajtar-Salwa R; Sorysz D; Zawiślak B; Suska A; Szostek M
Pol Arch Intern Med; 2022 Apr; 132(4):. PubMed ID: 35076194
[No Abstract] [Full Text] [Related]
30. Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.
Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Blau T; Reinhardt HC; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
J Neurol Sci; 2022 Sep; 440():120341. PubMed ID: 35872471
[TBL] [Abstract][Full Text] [Related]
31. Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.
Harrison JS; Frazier SR; McConnell DD; Yasar SJ; Melnyk N; Salaru G
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):342-347. PubMed ID: 27676646
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
[No Abstract] [Full Text] [Related]
33. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Grogan M; Dispenzieri A; Gertz MA
Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
[TBL] [Abstract][Full Text] [Related]
34. Arterial thromboembolism in senile systemic amyloidosis: report of two cases.
Nakagawa M; Tojo K; Sekijima Y; Yamazaki KH; Ikeda S
Amyloid; 2012 Jun; 19(2):118-21. PubMed ID: 22583098
[TBL] [Abstract][Full Text] [Related]
35. Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma.
Novosad O; Rudiuk T; Shevchuk L; Kundina V; Schmidt A
Carcinogenesis; 2023 May; 44(1):46-53. PubMed ID: 36661216
[TBL] [Abstract][Full Text] [Related]
36. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
[TBL] [Abstract][Full Text] [Related]
37. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis.
Feng D; Edwards WD; Oh JK; Chandrasekaran K; Grogan M; Martinez MW; Syed IS; Hughes DA; Lust JA; Jaffe AS; Gertz MA; Klarich KW
Circulation; 2007 Nov; 116(21):2420-6. PubMed ID: 17984380
[TBL] [Abstract][Full Text] [Related]
38. Amyloidosis in Heart Failure.
Ihne S; Morbach C; Obici L; Palladini G; Störk S
Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
[TBL] [Abstract][Full Text] [Related]
39. Primary systemic amyloidosis--a diagnostic primer.
Gertz MA; Kyle RA
Mayo Clin Proc; 1989 Dec; 64(12):1505-19. PubMed ID: 2513459
[TBL] [Abstract][Full Text] [Related]
40. Gastroparesis: an under-recognised manifestation of systemic amyloidosis.
Abdullah KM; Alsuraimi A; Kagbo-Kue S; Vela M
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
